Articles from Lowey Dannenberg, P.C.

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”) and thus were damaged by Defendants’ violations of Section 10(b) of the Exchange Act (the “Fraud Claim Class”); (b) held shares of Cerevel as of the January 8, 2024 record date (“Record Date”) and were entitled to vote on the merger of Cerevel and AbbVie Inc. (“AbbVie”) and thus were damaged by Defendants’ violations of Section 14(a) of the Exchange Act (the “Proxy Claim Class”); and (c) sold shares of Cerevel stock contemporaneously with Bain Capital’s purchase of shares on or about October 16, 2023 and thus were damaged by Bain’s violations of Section 20A of the Exchange Act (the “Insider Trading Claim Class,” and collectively with the Fraud Claim Class and the Proxy Claim Class, the “Class”).

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C.’s Data Privacy Team is investigating claims that data brokers and identity solution providers may be profiling consumers without consent or meaningful disclosures.

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against NET Power Inc. (“Net Power” or the “Company”) (NYSE: NPWR) for violations of the federal securities laws on behalf of investors who purchased or acquired Net Power common stock between June 9, 2023 and March 7, 2025, inclusive (the “Class Period”).

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI) for violations of the federal securities laws on behalf of investors who purchased or acquired BigBear common stock between March 31, 2022 and March 25, 2025, inclusive (the “Class Period”).

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C.’s Data Privacy Team is investigating claims that data brokers and identity solution providers may be profiling consumers without consent or meaningful disclosures.

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”) and thus were damaged by Defendants’ violations of Section 10(b) of the Exchange Act (the “Fraud Claim Class”); (b) held shares of Cerevel as of the January 8, 2024 record date (“Record Date”) and were entitled to vote on the merger of Cerevel and AbbVie Inc. (“AbbVie”) and thus were damaged by Defendants’ violations of Section 14(a) of the Exchange Act (the “Proxy Claim Class”); and (c) sold shares of Cerevel stock contemporaneously with Bain Capital’s purchase of shares on or about October 16, 2023 and thus were damaged by Bain’s violations of Section 20A of the Exchange Act (the “Insider Trading Claim Class,” and collectively with the Fraud Claim Class and the Proxy Claim Class, the “Class”).

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. is investigating potential claims regarding a data breach at California Cryobank LLC that occurred between April 20 – 22, 2024. To contact us regarding this investigation, please visit our website HERE and complete the form to speak with an attorney.

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”) and thus were damaged by Defendants’ violations of Section 10(b) of the Exchange Act (the “Fraud Claim Class”); (b) held shares of Cerevel as of the January 8, 2024 record date (“Record Date”) and were entitled to vote on the merger of Cerevel and AbbVie Inc. (“AbbVie”) and thus were damaged by Defendants’ violations of Section 14(a) of the Exchange Act (the “Proxy Claim Class”); and (c) sold shares of Cerevel stock contemporaneously with Bain Capital’s purchase of shares on or about October 16, 2023 and thus were damaged by Bain’s violations of Section 20A of the Exchange Act (the “Insider Trading Claim Class,” and collectively with the Fraud Claim Class and the Proxy Claim Class, the “Class”).

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) for violations of the federal securities laws on behalf of investors who purchased or acquired QCI common stock between March 30, 2020 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C.’s Data Privacy Team is investigating claims that data brokers and identity solution providers may be profiling consumers without consent or meaningful disclosures.

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQ: RKLB) for violations of the federal securities laws on behalf of investors who purchased or acquired Rocket Lab common stock between November 12, 2024 and February 25, 2025, inclusive (the “Class Period”).

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C.’s Data Privacy Team is investigating claims that data brokers and identity solution providers may be profiling consumers without consent or meaningful disclosures.

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) for violations of the federal securities laws on behalf of investors who purchased or acquired Venture Global common stock at the time of the Company’s Initial Public Offering (“IPO”) on January 24, 2025.

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSE: EIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQ: RKLB) for violations of the federal securities laws on behalf of investors who purchased or acquired Rocket Lab common stock between November 12, 2024 and February 25, 2025, inclusive (the “Class Period”).

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) for violations of the federal securities laws on behalf of investors who purchased or acquired QCI common stock between March 30, 2020 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Cerevel Therapeutics Holdings, Inc. (“Cerevel” or the “Company”) (NASDAQ: CERE) for violations of the federal securities laws on behalf of investors who: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel during the period from October 11, 2023 through August 1, 2024, inclusive (the “Class Period”) and thus were damaged by Defendants’ violations of Section 10(b) of the Exchange Act (the “Fraud Claim Class”); (b) held shares of Cerevel as of the January 8, 2024 record date (“Record Date”) and were entitled to vote on the merger of Cerevel and AbbVie Inc. (“AbbVie”) and thus were damaged by Defendants’ violations of Section 14(a) of the Exchange Act (the “Proxy Claim Class”); and (c) sold shares of Cerevel stock contemporaneously with Bain Capital’s purchase of shares on or about October 16, 2023 and thus were damaged by Bain’s violations of Section 20A of the Exchange Act (the “Insider Trading Claim Class,” and collectively with the Fraud Claim Class and the Proxy Claim Class, the “Class”).

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. is investigating potential claims regarding a data breach at California Cryobank LLC that occurred between April 20 – 22, 2024. To contact us regarding this investigation, please visit our website HERE and complete the form to speak with an attorney.

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. is investigating potential claims regarding a data breach at California Cryobank LLC that occurred between April 20 – 22, 2024. To contact us regarding this investigation, please visit our website HERE and complete the form to speak with an attorney.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) for violations of the federal securities laws on behalf of investors who purchased or acquired QCI common stock between March 30, 2020 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQ: RKLB) for violations of the federal securities laws on behalf of investors who purchased or acquired Rocket Lab common stock between November 12, 2024 and February 25, 2025, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSE: EIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) for violations of the federal securities laws on behalf of investors who purchased or acquired Venture Global common stock at the time of the Company’s Initial Public Offering (“IPO”) on January 24, 2025.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. is investigating potential claims regarding a data breach at California Cryobank LLC that occurred between April 20 – 22, 2024. To contact us regarding this investigation, please visit our website HERE and complete the form to speak with an attorney.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Fluence Energy, Inc. (“Fluence” or the “Company”) (NASDAQ: FLNC) for violations of the federal securities laws on behalf of investors who purchased or acquired Fluence common stock between November 29, 2023 to February 10, 2025, inclusive (the “Class Period”).

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) for violations of the federal securities laws on behalf of investors who purchased or acquired AppLovin common stock between May 10, 2023 and February 25, 2025, inclusive (the “Class Period”).

NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg, P.C. is investigating potential claims regarding a data breach at California Cryobank LLC that occurred between April 20 – 22, 2024. To contact us regarding this investigation, please visit our website HERE and complete the form to speak with an attorney.

NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against AppLovin Corporation (“AppLovin” or the “Company”) (NASDAQ: APP) for violations of the federal securities laws on behalf of investors who purchased or acquired AppLovin common stock between May 10, 2023 and February 25, 2025, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) for violations of the federal securities laws on behalf of investors who purchased or acquired Venture Global common stock at the time of the Company’s Initial Public Offering (“IPO”) on January 24, 2025.

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQ: FTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSE: EIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Maravai LifeSciences Holdings, Inc. (“Maravai” or the “Company”) (NASDAQ: MRVI) for violations of the federal securities laws on behalf of investors who purchased or acquired Maravai common stock between August 7, 2024 and February 24, 2025, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Rocket Lab USA, Inc. (“Rocket Lab” or the “Company”) (NASDAQ: RKLB) for violations of the federal securities laws on behalf of investors who purchased or acquired Rocket Lab common stock between November 12, 2024 and February 25, 2025, inclusive (the “Class Period”).

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Quantum Computing Inc. (“QCI” or the “Company”) (NASDAQ: QUBT) for violations of the federal securities laws on behalf of investors who purchased or acquired QCI common stock between March 30, 2020 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSE: EIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) for violations of the federal securities laws on behalf of investors who purchased or acquired Venture Global common stock at the time of the Company’s Initial Public Offering (“IPO”) on January 24, 2025.

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQ: FTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX) for violations of the federal securities laws on behalf of investors who purchased or acquired TransMedics common stock between February 28, 2023 and January 10, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) for violations of the federal securities laws on behalf of investors who purchased or acquired Venture Global common stock at the time of the Company’s Initial Public Offering (“IPO”) on January 24, 2025.

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQ: FTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQ: FTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) for violations of the federal securities laws on behalf of investors who purchased or acquired Novo common stock between November 2, 2022 to December 19, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ: NMRA) for violations of the federal securities laws on behalf of investors who purchased or acquired Neumora common stock at the time of the Company’s Initial Public Offering (“IPO”) on September 15, 2023.

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating TransMedics Group, Inc. (“TransMedics”) (NASDAQ:TMDX) for potential violations of the federal securities laws.

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Edison International (“Edison” or the “Company”) (NYSE: EIX) for violations of the federal securities laws on behalf of investors who purchased or acquired Edison common stock between February 25, 2021 and February 6, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ: IAS) for violations of the federal securities laws on behalf of investors who purchased or acquired IAS common stock between March 2, 2023, and February 27, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQ: FTAI) for violations of the federal securities laws on behalf of investors who purchased or acquired FTAI common stock between July 23, 2024 and January 15, 2025, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) for violations of the federal securities laws on behalf of investors who purchased or acquired Pacira common stock between August 2, 2023 to August 8, 2024, inclusive (the “Class Period”).

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ: CROX) for violations of the federal securities laws on behalf of investors who purchased or acquired Crocs common stock between November 3, 2022, and October 28, 2024, inclusive (the “Class Period”).